DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/ndczhq/botulinum_toxin) has announced the addition of the "Botulinum Toxin - Global Strategic Business Report" report to their offering.
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs.
This report analyzes the worldwide markets for Botulinum Toxin in US$ Million by the following Segments:
- Cosmetic Applications
- Therapeutic Applications
The report profiles 19 companies including many key and niche players such as:
- Allergan, Inc.
- Ipsen Group
- Medy-Tox Incorporated
- Mentor Corporation
- Merz Pharma GmbH & Co. KGaA
- Metabiologics, Inc.
- Revance Therapeutics, Inc.
- US WorldMeds
Key Topics Covered:
I. Introduction, Methodology & Product Definitions
II. Executive Summary
1. Industry Overview
2. Competition
3. Market Trends & Issues
4. Product/Industry Dynamics
5. Product Overview
6. Research Breakthroughs
7. Product Introductions/Approvals
8. Recent Industry Activity
9. Focus On Select Global Players
10. Global Market Perspective
III. Market
1. The United States
2. Canada
3. Japan
4. Europe
5. Asia-Pacific
6. Rest Of World
IV. Competitive Landscape
Total Companies Profiled: 19 (including Divisions/Subsidiaries - 23)
- The United States (9)
- Japan (2)
- Europe (6)
- -France (1)
- - Germany (1)
- - The United Kingdom (3)
- - Rest of Europe (1)
- Asia-Pacific (Excluding Japan) (6)
For more information visit http://www.researchandmarkets.com/research/ndczhq/botulinum_toxin
